- Not Fee assured
- Verified this account
You'll need to contact this healthcare professional to check their availability
- Sexual and reproductive healthcare
Sohier Elneil is a Consultant Urogynaecologist and Gynaecologist at University College Hospital and the National Hospital for Neurology and Neurosurgery in London. She started her career in the field of Urogynaecology in the 1990’s. This included the specialist assessment, investigation, diagnosis and management of urinary incontinence, faecal incontinence, and utero-vaginal prolapse. All of these urogynaecological problems led her to pursue further surgical training in gynaecology, urology and aspects of colorectal surgery in order to become proficient in performing complex reconstructive pelvic floor surgery, laparoscopic continence and prolapse surgery, as well as general and complex gynaecological procedures.
Her research interest led her on to do her PhD at the University of Cambridge to study the physiology and pharmacology of sensory bladder dysfunction in women.This led to her interest in the investigation, diagnoses and treatment of patients with neurological bladder dysfunction. At the National Hospital for Neurology and Neurosurgery, Queen Square in London, she is the lead for the sacral neuromodulator programme for intractable bladder and pelvic floor dysfunction.
In her career in Urogynaecology and Uro-neurology over the last 10 years, as a Consultant, she has become increasingly involved in research, as well as teaching and training of junior and senior colleagues in the two specialities in the UK and further afield. This has included being an invited speaker, chairing workshops and teaching at University College London, the Royal College of Obstetricians and Gynaecologists, the Royal College of Surgeons, the International Federation of Gynaecologists and Obstetrics and numerous professional organizations, including the European Association of Urology, International Continence Society, International Urogynaecology Association, Pan African Urological Surgeons Association and many others. In the last eight years she has worked closely with many pharmaceutical and devices companies, both in the UK, Europe and in the USA. In particular, she has been involved in devising courses and teaching sessions with Astellas, Pfizer, Allergan and Medtronic. Astellas, in particular, has had a huge impact in continuing medical education in the UK and abroad. She has been privileged to be part of UK and Global advisory board meetings for Astellas, Allergan and Medtronic, to name the principal three. She continues to work with all of them in their training programmes for specialist urologists, urogynaecologists and neurologists, and also for general practitioners, nurses and other affiliated scientific and clinical groups.
Miss Elneil is the Training Programme Director for Urogynaecology at University College London Hospitals, Clinical lead for Uro-neurology training for all UK trainees undertaking the RCOG-accredited sub-speciality training programme, Chair of the International Continence Society (ICS) Fistula Committee, Member of the ICS Standardization Committee, Member of the EAU Chronic Pelvic Pain Committee, Chair of the IUGA working group on Chronic Pelvic Pain, Author/Editor of the FIGO and partners Fistula training manual and numerous other positions. She feels privileged and honoured to have been chosen to help run and devise strategy within these groups.
Her academic aims remain the study of the neurological basis of bladder and pelvic floor dysfunction, and the determination of new therapeutic targets to improve continence and pelvic floor management in women. This will not only include the scientific basis of these conditions, but also how these conditions impact on the individual, their families and society.
Areas of interest
Urogynaecology; Uro-neurology; Neuro-urogynaecology; Urodynamics; Urinary and Faecal Incontinence; Prolapse surgery; Genital Tract Fistulas; Abdominal and Pelvic pain in Women; Continence and Prolapse Mesh Removal; Sacral Neuromodulation for intractable bladder/bowel dysfunction; Botulinum Toxin Therapy in intractable bladder and pelvic floor disorders
- Arlene Pihel
- The London Clinic 5 Devonshire Place London W1G 6HL
- 020 7034 6245
- Delia Kadiri
- The London Clinic 5 Devonshire Place London W1G 6HL
- 020 7034 6246
- 020 7299 0142
Anaesthetists worked with
- Dr Ian R Barker Fee Assured
- Member of Board of Trustees Operation Fistula
- Chair of the International Continence Society Fistula Committee
- Member of Board of Trustees Medical Aid Films
Current NHS consultant posts held
Consultant in Urogynaecology and Uro-neurology
University College London Hospital & National Hospital for Neurology &Neurosurgery
Honorary Senior Lecturer, Institute for Women’s Health, UCL, London
Honorary Senior Lecturer, Lucy Cavendish College, University of Cambridge
• Bowel dysfunction in chronic urinary retention in women (Fowlers Syndrome), pre and post neuromodualtion
• Sacral neuromodulation in spinal cord injury patients
• Pudendal neuromodulation in neurogenic detrusor overactivity
• Effect of botulinum toxin on the urothelium: purinergic neurotransmission and calcium metabolism
• Botulinum toxin in idiopathic detrusor over-activity
• Botulinum toxin in the treatment of bladder pain syndrome: dose-effect study
Teaching and training junior medical personnel in under-resourced settings
Community group work in diaspora communities
2009: Moslem Women of the Year Award
2018: BBC One Show and National Patient Association Doctor of the Year Celebrating 70 Years of the NHS
2018: Daily Mail Health Hero
(Additional) Languages spoken
- Arabic - Native or bilingual
- French - Conversational
Zecca, C., et al., Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis: an open label, multicenter, prospective study. J Urol, 2014. 191(3): p. 697-702.
2. Elneil, S., et al., Optimizing the duration of assessment of stage-1 sacral neuromodulation in nonobstructive chronic urinary retention. Neuromodulation, 2014. 17(1): p. 66-70; discussion 70-1.
3. Adams, A., et al., Neural stimulators: A guide to imaging and postoperative appearances. Clin Radiol, 2014.
4. Khunda, A., et al., Pregnancy in women with Fowler's syndrome treated with sacral neuromodulation. Int Urogynecol J, 2013. 24(7): p. 1201-4.
5. Engeler, D.S., et al., The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol, 2013. 64(3): p. 431-9.
6. Bhide, A.A., et al., Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature. Int Urogynecol J, 2013. 24(9): p. 1429-34.
7. Barker, R.A., et al., The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease. J Neurol Neurosurg Psychiatry, 2013. 84(6): p. 657-65.
8. Tubaro, A., et al., The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review. Curr Urol Rep, 2012. 13(5): p. 335-42.
9. Panicker, J.N., et al., The possible role of opiates in women with chronic urinary retention: observations from a prospective clinical study. J Urol, 2012. 188(2): p. 480-4.
10. Hanno, P., et al., Chronic pelvic pain syndrome/bladder pain syndrome: taking stock, looking ahead: ICI-RS 2011. Neurourol Urodyn, 2012. 31(3): p. 375-83.
11. Khan, S., et al., Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis. J Urol, 2011. 185(4): p. 1344-9.
12. Game, X., et al., Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity. BJU Int, 2011. 107(11): p. 1786-92.
Courses offered to GPs
As part of HCA, I regularly take part in GP seminars and talks.
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.http://www.rcog.org.uk
0.3% Re-admission Rate
4% Infection Rate (urinary tract infection)
0% Mortality Rate
6/6 In recent 360 appraisal by patients, suggesting excellent patient care
- Medical Degree University of Zimbabwe 1987
- MRCOG RCOG 1994
- FRCOG RCOG 2014
- Urogynaecology and Uro-neurology University College London Hospitals 2004
- Uogyanecology Sub-specialist on GMC Register RCOG 2004
- PhD in Pharmacology University of Cambridge 2002
Reference number 4157384
Professional bodies (positions held - last 3 yrs)
- Chair of International Continence Society Fistula Terminology Group ICS 2017
- Immediate Past President RSM Paun Coouncil Royal Society of Medicine 2017
- Chair RCOG Global Health Management Committee RCOG 2016
Details of entry to specialist register
- CCT, 2004
- Sub-specialist in Urogynaecology, 2004
Affiliations / memberships
- The London Clinic5 Devonshire PlaceLondonW1G 6HL
- 10:00 - 18:00
- 020 7034 6245
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
In the case of an emergency post-surgery, patients can first see their GP, then consider a review in A&E and if required they can also call the London Clinic on 02076314448.
In the case of a non-surgical emergency, please see your GP or attend the local Accident and Emergency Department
For non-urgent calls out of hours, please leave a message on the practice answerphone or e-mail: email@example.com or firstname.lastname@example.org or email@example.com
Other ways of contacting me
I can be contacted directly using Skype. My Skype ID is: sohierq